Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
New facility is equipped with state-of-the-art analytical equipment through a collaboration with Shimadzu Corporation.
June 9, 2021
By: Tim Wright
CatSci Ltd. has opened a new analytical science laboratory in Dagenham, UK. The new facility is equipped with state-of-the-art analytical equipment through a collaboration with Shimadzu Corporation. A key early milestone in CatSci’s $3.5 million investment plan, this new dedicated analytical resource further positions CatSci as an innovation partner in medicines development that can add strategic value to customers, addressing their evolving CMC challenges and de-risking their pharmaceutical pipelines. The demand for solving multi-disciplinary analytical problems is growing with the advent of new modalities and asset classes, such as oligonucleotides and cannabinoids. At the same time, new or modified regulatory requirements such as nitrosamine determinations and trace impurity analysis require the development of highly specific and sensitive methods. “The opening of our analytical laboratory at LondonEast in Dagenham, UK is an exciting step on our journey towards becoming a fully integrated CMC company that accelerates medicine development to deliver best-in-class therapeutics to those in need,” said Ross Burn, CEO, CatSci. “Solving complex challenges that our customers face is at the core of what we do and this new facility, filled with Shimadzu’s cutting-edge equipment, sets a new exemplary standard for measurement science in the industry.” Nigel Richardson, director of analytical technology and new modalities, said, “We’re excited to leverage our large pharma heritage across the CMC landscape and excellence in analytical science to work seamlessly with our customers to solve their analytical chemistry challenges with speed and scientific integrity. The opening of this new facility deepens the level of support we can offer. We will also be upgrading the site with capacity for GMP analytical development and testing, which will further increase our ability to provide innovative, tailored solutions from early development pre-clinical data packages to late development Phase III impurity fate studies.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !